The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling
Open accessAbstract
Multiple genetic and environmental factors play a role in the development and progression of Parkinson's disease (PD). The main neuropathological hallmark of PD is the degeneration of dopaminergic (DAergic) neurons in the substantia nigra pars compacta. To study genetic and molecular contributors to the disease process, there is a great need for readily accessible cells with prominent DAergic features that can be used for reproducible in vitro cellular screening. Here, we investigated the molecular phenotype of retinoic acid (RA) differentiated SH-SY5Y cells using genome wide transcriptional profiling combined with gene ontology, transcription factor and molecular pathway analysis. We demonstrated that RA induces a general neuronal differentiation program in SH-SY5Y cells and that these cells develop a predominantly mature DAergic-like neurotransmitter phenotype. This phenotype is characterized by increased dopamine levels together with a substantial suppression of other neurotransmitter phenotypes, such as those for noradrenaline, acetylcholine, glutamate, serotonin and histamine. In addition, we show that RA differentiated SH-SY5Y cells express the dopamine and noradrenalin neurotransmitter transporters that are responsible for uptake of MPP(+), a well known DAergic cell toxicant. MPP(+) treatment alters mitochondrial activity according to its proposed cytotoxic effect in DAergic neurons. Taken together, RA differentiated SH-SY5Y cells have a DAergic-like phenotype, and provide a good cellular screening tool to find novel genes or compounds that affect cytotoxic processes that are associated with PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“So far, several cellular defects, such as the formation of Lewy bodies [8,9], mitochondrial dysfunction and increased oxidative stress, have been linked to the disease, although these cannot fully explain the molecular basis of the disease [10].”
BackgroundSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
GOstat: find statistically overrepresented Gene Ontologies within a group of genes
Beißbarth, T., & Speed, T. P. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth088 · Cited by 1,257
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Retinoic acid in the development, regeneration and maintenance of the nervous system
Maden, M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2212 · Cited by 896
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 783
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones.
Biedler, J. L., Roffler-Tarlov, S. K., Schachner, M., & Freedman, L. S. (1978) · PubMed · Cited by 759
Cheung, Y.-T., Lau, W. K.-W., Yu, M.-S., Lai, C. S.-W., Yeung, S.-C., So, K.-F., & Chang, R. C.-C. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2008.11.001 · Cited by 576 · cited 3×
“However, others did not observe changes in the expression of key DAergic-cell markers in RA treated cells [21].”
BackgroundParkinson's--Divergent Causes, Convergent Mechanisms
Greenamyre, J. T., & Hastings, T. G. (2004) · Science · doi:10.1126/science.1098966 · Cited by 451
Castro, D. S., Martynoga, B., Parras, C., Ramesh, V., Pacary, E., Johnston, C., Drechsel, D., Lebel-Potter, M., Garcia, L. G., Hunt, C., et al. (2011) · Genes & Development · doi:10.1101/gad.627811 · Cited by 407
Lopes, F. M., Schröder, R., Júnior, M. L. C. D. F., Zanotto-Filho, A., Müller, C. B., Pires, A. S., Meurer, R. T., Colpo, G. D., Gelain, D. P., Kapczinski, F., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.102 · Cited by 388
Gr�nblatt, E., Mandel, S., Jacob-Hirsch, J., Zeligson, S., Amariglo, N., Rechavi, G., Li, J., Ravid, R., Roggendorf, W., Riederer, P., et al. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0212-1 · Cited by 356
How to make a mesodiencephalic dopaminergic neuron
Smidt, M. P., & Burbach, J. P. H. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2039 · Cited by 355
Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., Andersen, S. L., Stephens, R. M., Benes, F. M., & Sonntag, K. C. (2009) · Brain · doi:10.1093/brain/awn323 · Cited by 354
Kaplan, D. R., Matsumoto, K., Lucarelli, E., & Thielet, C. J. (1993) · Neuron · doi:10.1016/0896-6273(93)90187-v · Cited by 345
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Lotharius, J., & O'Malley, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005385200 · Cited by 306
López-Carballo, G., Moreno, L., Masiá, S., Pérez, P., & Barettino, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201869200 · Cited by 301
Zhang, Y., James, M., Middleton, F. A., & Davis, R. L. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30195 · Cited by 258
First demonstration of highly specific and sensitive antibodies against dopamine
Geffard, M., Buijs, R. M., Seguela, P., Pool, C. W., & Le Moal, M. (1984) · Brain Research · doi:10.1016/0006-8993(84)91323-4 · Cited by 250
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease
Moran, L. B., Duke, D. C., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2006) · neurogenetics · doi:10.1007/s10048-005-0020-2 · Cited by 242
GABAergic control of substantia nigra dopaminergic neurons
Tepper, J. M., & Lee, C. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(06)60011-3 · Cited by 238
Multiple risk factors for Parkinson's disease
Gorell, J. M., Peterson, E. L., Rybicki, B. A., & Johnson, C. C. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.09.014 · Cited by 230
Bossers, K., Meerhoff, G., Balesar, R., Van Dongen, J. W., Kruse, C. G., Swaab, D. F., & Verhaagen, J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00171.x · Cited by 173
Self-citationCholinergic modulation of midbrain dopaminergic systems
Mena-Segovia, J., Winn, P., & Bolam, J. P. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.02.003 · Cited by 172
Polyamine pathway contributes to the pathogenesis of Parkinson disease
Lewandowski, N. M., Ju, S., Verbitsky, M., Ross, B., Geddie, M. L., Rockenstein, E. M., Adame, A., Muhammad, A., Vonsattel, J. P., Ringe, D., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011751107 · Cited by 172
Schwarzer, C., Berresheim, U., Pirker, S., Wieselthaler, A., Fuchs, K., Sieghart, W., & Sperk, G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1158 · Cited by 165
In vivo imaging of synaptic function in the central nervous system
Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.008 · Cited by 163
BMPs inhibit neurogenesis by a mechanism involving degradation of a transcription factor
Shou, J., Rim, P. C., & Calof, A. L. (1999) · Nature Neuroscience · doi:10.1038/7251 · Cited by 163
MANDEL, S., GRUNBLATT, E., RIEDERER, P., AMARIGLIO, N., HIRSCH, J. J., RECHAVI, G., & YOUDIM, M. B. H. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00044.x · Cited by 158
Hauser, M. A., Li, Y.-J., Xu, H., Noureddine, M. A., Shao, Y. S., Gullans, S. R., Scherzer, C. R., Jensen, R. V., McLaurin, A. C., Gibson, J. R., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.917 · Cited by 158
Zimmermann, M., Gardoni, F., Marcello, E. E., Colciaghi, F., Borroni, B., Padovani, A., Cattabeni, F., & Luca, M. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02680.x · Cited by 143
Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.009 · Cited by 143
Axonal netrin-Gs transneuronally determine lamina-specific subdendritic segments
Nishimura-Akiyoshi, S., Niimi, K., Nakashiba, T., & Itohara, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706919104 · Cited by 132
Stam, F. J., MacGillavry, H. D., Armstrong, N. J., de Gunst, M. C. M., Zhang, Y., van Kesteren, R. E., Smit, A. B., & Verhaagen, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05597.x · Cited by 132
Self-citationApoptotic molecules and MPTP-induced cell death
Nicotra, A., & Parvez, S. H. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00213-1 · Cited by 121
Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease
Miller, R. M., Kiser, G. L., Kaysser-Kranich, T., Lockner, R., Palaniappan, C., & Federoff, H. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.010 · Cited by 119
Paquet, M., Tremblay, M. W., Soghomonian, J., & Smith, Y. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01377.1997 · Cited by 105
Nakamura, K., Bindokas, V. P., Marks, J. D., Wright, D. A., Frim, D. M., Miller, R. J., & Kang, U. J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.271 · Cited by 105
Miloso, M., Villa, D., Crimi, M., Galbiati, S., Donzelli, E., Nicolini, G., & Tredici, G. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10848 · Cited by 104
Nrf2 promotes neuronal cell differentiation
Zhao, F. L., Wu, T., Lau, A., Jiang, T., Huang, Z., Wang, X.-J., Chen, W., Wong, P. K., & Zhang, D. D. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.029 · Cited by 103
Bustos, G. A., Abarca, J., Campusano, J. M., Bustos, V., Noriega, V., & Aliaga, E. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.05.002 · Cited by 102
Pan, J., Kao, Y., Joshi, S., Jeetendran, S., DiPette, D., & Singh, U. S. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03106.x · Cited by 94 · cited 1×
“These include NRF2, a transcription factor regulating the endogenous antioxidant response and neuronal differentiation [67], integrin a1 and ß1, cell membrane receptors involved in cell adhesion and recognition [28], and the Rho GTPase RAC1, a neurite outgrowth initiator [29].”
BackgroundIdentification of GABAAreceptor subunit variants in midbrain dopaminergic neurons
Okada, H., Matsushita, N., Kobayashi, K., & Kobayashi, K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02271.x · Cited by 80
N-myc Promotes Survival and Induces S-Phase Entry of Postmitotic Sympathetic Neurons
Wartiovaara, K., Barnabé‐Heider, F., Miller, F. D., & Kaplan, D. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00815.2002 · Cited by 74
Pifl, C., Hornykiewicz, O., Giros, B., & Caron, M. G. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13093-0 · Cited by 72
Insulin Modulates Cocaine-Sensitive Monoamine Transporter Function and Impulsive Behavior
Schoffelmeer, A. N. M., Drukarch, B., Vries, T. J. D., Hogenboom, F., Schetters, D., & Pattij, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3779-10.2011 · Cited by 70
Cuende, J., Moreno, S., Bolaños, J. P., & Almeida, Á. (2008) · Oncogene · doi:10.1038/sj.onc.1210987 · Cited by 70
Bonifati, V. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70008-7 · Cited by 60
Albers, D. S., Weiss, S. W., Iadarola, M. J., & Standaert, D. G. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00328-5 · Cited by 54
NCAM2/OCAM/RNCAM: Cell adhesion molecule with a role in neuronal compartmentalization
Winther, M., Berezin, V., & Walmod, P. S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.11.020 · Cited by 50
Saraf, A., Virshup, D. M., & Strack, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607407200 · Cited by 48
Truckenmiller, M. E., Vawter, M. P., Cheadle, C., Coggiano, M. A., Donovan, D. M., Freed, W. J., & Becker, K. G. (2001) · PubMed · Cited by 36
Single-cell cDNA microarray profiling of complex biological processes of differentiation
Kurimoto, K., & Saitou, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.06.003 · Cited by 35
Analysis of gene expression in neural cells subject to chronic proteasome inhibition
Ding, Q., Bruce‐Keller, A. J., Chen, Q., & Keller, J. N. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.025 · Cited by 33
Verney, C. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.08.002 · Cited by 25
Fluorescent differential display analysis of gene expression in differentiating neuroblastoma cells
Kito, K., Ito, T., & Sakaki, Y. (1997) · Gene · doi:10.1016/s0378-1119(96)00577-x · Cited by 21
Bossers, K., Ylstra, B., Brakenhoff, R. H., Smeets, S. J., Verhaagen, J., & van de Wiel, M. A. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-112 · Cited by 19
Self-citationBrill, L. B., & Bennett, J. P. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00045-6 · Cited by 17
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036
Nagy, C., Maitra, M., Tanti, A., Suderman, M., Théroux, J.-F., Davoli, M. A., Perlman, K., Yerko, V., Wang, Y. C., Tripathy, S. J., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0621-y · Cited by 532
Nagy, C., Maitra, M., Tanti, A., Suderman, M., Théroux, J.-F., Mechawar, N., Ragoussis, J., & Turecki, G. (2018) · doi:10.1101/384479 · Cited by 523
Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
Shipley, M. M., Mangold, C. A., & Szpara, M. L. (2016) · Journal of Visualized Experiments · doi:10.3791/53193 · Cited by 446
In vitro Models of Neurodegenerative Diseases
Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00328 · Cited by 290
Metadata
- Authors
- Korecka, J. A., van Kesteren, R. E., Blaas, E., Spitzer, S. O., Kamstra, J. H., Smit, A. B., Swaab, D. F., Verhaagen, J., & Bossers, K.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-28
- Volume
- 8
- Issue
- 5
- Pages
- e63862
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1966911546
- Cited by
- 253
- References
- 66
- FWCI
- 11.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.